Expression of BCMA, TACI, and BAFF-R in multiple myeloma: a mechanism for growth and survival
Top Cited Papers
Open Access
- 15 January 2004
- journal article
- Published by American Society of Hematology in Blood
- Vol. 103 (2), 689-694
- https://doi.org/10.1182/blood-2003-06-2043
Abstract
Multiple myeloma (MM) is a progressive disease that is thought to result from multiple genetic insults to the precursor plasma cell that ultimately aKeywords
This publication has 29 references indexed in Scilit:
- Macrophage- and dendritic cell—dependent regulation of human B-cell proliferation requires the TNF family ligand BAFFBlood, 2003
- BAFF and APRIL: A Tutorial on B Cell SurvivalAnnual Review of Immunology, 2003
- G-CSF–stimulated Neutrophils Are a Prominent Source of Functional BLySThe Journal of Experimental Medicine, 2003
- Molecular mechanisms of novel therapeutic approaches for multiple myelomaNature Reviews Cancer, 2002
- Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survivalBlood, 2002
- A molecular compendium of genes expressed in multiple myelomaBlood, 2002
- The role of nuclear factor-?b in the biology and treatment of multiple myelomaSeminars in Oncology, 2001
- BAFF-R, a Newly Identified TNF Receptor That Specifically Interacts with BAFFScience, 2001
- The role of tumor necrosis factor α in the pathophysiology of human multiple myeloma: therapeutic applicationsOncogene, 2001
- Baff Binds to the Tumor Necrosis Factor Receptor–Like Molecule B Cell Maturation Antigen and Is Important for Maintaining the Peripheral B Cell PopulationThe Journal of Experimental Medicine, 2000